Oesophageal cancer risk | Cancer Research UK
COG : Gefitinib for oesophageal cancer progressing after chemotherapy — Department of Oncology
Peri-operative therapy for operable gastroesophageal adenocarcinoma: past, present and future - Annals of Oncology
Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study | The BMJ
Oesophageal cancer risk | Cancer Research UK
Barrett's oesophagus | Signs and symptoms - Macmillan Cancer Support
Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka
About Us — Department of Oncology
Pembrolizumab Approved for Esophageal Cancer - NCI
Frontiers | “Targeted” Chemotherapy for Esophageal Cancer
Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study) - eClinicalMedicine
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial - The Lancet Gastroenterology & Hepatology
Advances in the curative management of oesophageal cancer | British Journal of Cancer
Cell-free DNA analysis in current cancer clinical trials: a review | British Journal of Cancer
Men's oesophageal cancer risk "triple that of women" - PMLiVE
Advances in targeted therapy for esophageal cancer | Signal Transduction and Targeted Therapy
A trial looking at improving chemoradiotherapy for people with cancer of the food pipe (SCOPE 2) | Cancer Research UK
Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends | Nature Reviews Gastroenterology & Hepatology
A trial of additional treatment for oesophageal cancer and stomach cancer (PLATFORM) | Cancer Research UK
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Stage 0 (high grade dysplasia) | Oesophageal cancer | Cancer Research UK
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma | NEJM
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial - The Lancet Oncology
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction - Annals of Oncology
Oesophageal carcinoma - The Lancet
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 -
